LATE-ONSET HYPERTROPHIC CARDIOMYOPATHY

2019 ◽  
Vol 73 (9) ◽  
pp. 2373
Author(s):  
Asad J. Torabi ◽  
Hossein Ouranos ◽  
Richard Kovacs
1998 ◽  
Vol 338 (18) ◽  
pp. 1248-1257 ◽  
Author(s):  
Hideshi Niimura ◽  
Linda L. Bachinski ◽  
Somkiat Sangwatanaroj ◽  
Hugh Watkins ◽  
Albert E. Chudley ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Paal Skytt Andersen ◽  
Paula Louise Hedley ◽  
Stephen P. Page ◽  
Petros Syrris ◽  
Johanna Catharina Moolman-Smook ◽  
...  

Hypertrophic cardiomyopathy (HCM) is caused by mutations in genes encoding sarcomere proteins. Mutations inMYL3, encoding the essential light chain of myosin, are rare and have been associated with sudden death. Both recessive and dominant patterns of inheritance have been suggested. We studied a large family with a 38-year-old asymptomatic HCM-affected male referred because of a murmur. The patient had HCM with left ventricular hypertrophy (max WT 21 mm), a resting left ventricular outflow gradient of 36 mm Hg, and left atrial dilation (54 mm). Genotyping revealed heterozygosity for a novel missense mutation, p.V79I, inMYL3. The mutation was not found in 300 controls, and the patient had no mutations in 10 sarcomere genes. Cascade screening revealed a further nine heterozygote mutation carriers, three of whom had ECG and/or echocardiographic abnormalities but did not fulfil diagnostic criteria for HCM. The penetrance, if we consider this borderline HCM the phenotype of the p.V79I mutation, was 40%, but the mean age of the nonpenetrant mutation carriers is 15, while the mean age of the penetrant mutation carriers is 47. The mutation affects a conserved valine replacing it with a larger isoleucine residue in the region of contact between the light chain and the myosin lever arm. In conclusion,MYL3mutations can present with low expressivity and late onset.


Circulation ◽  
2002 ◽  
Vol 105 (12) ◽  
pp. 1407-1411 ◽  
Author(s):  
B. Sachdev ◽  
T. Takenaka ◽  
H. Teraguchi ◽  
C. Tei ◽  
P. Lee ◽  
...  

2008 ◽  
Vol 39 (3) ◽  
pp. 233-237 ◽  
Author(s):  
Yoshiro Nagao ◽  
Haruko Nakashima ◽  
Yukiko Fukuhara ◽  
Michie Shimmoto ◽  
Akihiro Oshima ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
G Vitale ◽  
F Di Nicola ◽  
I Tanini ◽  
A Camporeale ◽  
F Graziani ◽  
...  

Abstract Background Differential diagnosis between Anderson-Fabry (AF) and sarcomeric hypertrophic cardiomyopathy (HCM) is often very challenging particularly in AF patients with late onset cardiac involvement. Purpose To gain new insights from standard electrocardiogram (ECG) in AF disease for differential diagnosis from sarcomeric HCM. Additionally, to better understand ECG features in AF patients, a correlation substudy ECG-cardiac magnetic resonance (CMR) has been performed. Methods From 162 patients with definite diagnosis of AF disease, 111 [65 males, median age 57 (51–67) years] with pathologic left ventricular hypertrophy (LVH) (Group A) were compared with 111 sarcomeric HCM patients (Group B) sex, age and maximal wall thickness matched by 1:1 propensity score. Results AF patients showed shorter PR interval [155 (140–180) vs 163 (149–184) msec; p=0.005) and wider QRS interval [110 (100–134) vs 100 (90–106) msec; p<0.0001). Additionally AF patients had a higher prevalence of complete (22% vs 3%; p<0.0001) and incomplete (13% vs 1%; p<0.0001) right bundle branch block (RBBB) and a higher percentage of ST segment depression (12% vs 1%; p=0.001) and inferior negative T waves (34% vs 19%; p=0.01). No differences in terms of Sokolow-Lyon and Cornell scores were found whereas total QRS score was higher in Group A [20 (16–27) vs 18 [14–22] mV; p=0.0004). Low QRS voltages and inferior Q waves were not present in AF patients. Among the 69 AF patients who underwent MRI, the 44 with late gadolinium enhancement (LGE) were older [59 (52–66) vs 53 (40–59) years; p=0.017] and had more frequently negative T waves on ECG, particularly in the inferior leads (64% vs 8%; p<0.0001), compared to the 25 without LGE. At multivariate analysis, age and negative T waves were independently associated to the presence of LGE on CMR. Conclusions Compared to matched sarcomeric HCM, AF patients had a shorter PR, wider QRS and a higher percentage of RBBB in relation to to the different aetiology (storage vs “pure” hypertrophy). The higher total QRS score and the absence of inferior Q waves could reflect the more frequent concentric distribution of LVH. Additionally negative T waves, especially in inferior leads, are related to the presence of LGE on CMR (often in the postero-lateral wall). Funding Acknowledgement Type of funding source: None


Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Ryan P Daly ◽  
E. Rene Rodriguez ◽  
Allan L Klein

A 73-year-old woman with a history of hypertension (HTN) and mild aortic insufficiency (AI) presented to clinic with progressive dyspnea, fatigue and decreased functional capacity. Her family history was remarkable for a 45-year-old son with a “weak heart” and kidney dysfunction that was being evaluated. Her physical exam was unremarkable with the exception of bradycardia. ECG revealed sinus bradycardia of 46-bpm and a complete RBBB. Transthoracic echo revealed a small cavity with severely increased wall thickness, with obliteration in systole, with no obstruction and mild AI; notably without a history of poorly controlled HTN or significant valvular disease. A right heart catheterization revealed low output failure with a FICK cardiac index of 1.9 L/min-m2. Of note, her son’s work-up revealed Fabry’s disease, with cardiac and renal involvement. Her alpha-galactosidase enzyme levels were low-normal. A cardiac MRI with late gadolinium enhancement revealed a pattern of fibrosis suggestive infiltrative disease, and atypical for HOCM. Endocardial biopsy demonstrated myelin figures with curvilinear bodies in multiple myocytes on ultrastructural examination, diagnostic for cardiac Fabry’s disease. Enzymatic replacement therapy was initiated and a DDD pacemaker was placed with improvement of her NYHA class and BNP level. A treatable disease, representing up to 4% of late-onset hypertrophic cardiomyopathy (HCM), Fabry’s disease should be considered when evaluating patients with non-obstructive HCM. Keys to establishing this diagnosis lay in integrating clinical, genetic, and imaging data and recognizing Fabry’s disease as an X-linked dominant (not recessive) disease that may have isolated cardiac involvement, in heterozygous females, despite low-normal alpha-galactosidase activity.


2016 ◽  
Vol 117 (2) ◽  
pp. S24
Author(s):  
Lauren A. Bailey ◽  
Mari Mori ◽  
Deeksha Bali ◽  
Anne F. Buckley ◽  
Priya S. Kishnani

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. P2958-P2958
Author(s):  
C. Quarta ◽  
S. Longhi ◽  
F. Cappelli ◽  
F. Perfetti ◽  
A. Ferlini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document